ArticleAddiction (Abingdon, England)2019
Time since first cannabis use and 12-month prevalence of cannabis use disorder among youth and emerging adults in the United States.
Article in Addiction (Abingdon, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 76 citations in OpenAlex.
- Text message-delivered cannabis use disorder treatment with young adults: A large randomized clinical trial.Journal of substance use and addiction treatment · 2025Trial
- Relationship between patterns of cannabis use and functional and symptomatic trajectories in first-episode psychosis.European archives of psychiatry and clinical neuroscience · 2023Trial
- Associations Between Youth Marijuana and Alcohol Use, Neurocognitive Performance, and Triple-Network Resting-State Connectivity.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2026Article
- Narrowing and Reversing Sex Gaps in Cannabis Use and Cannabis Use Disorder Among Adolescents and Young Adults.Journal of studies on alcohol and drugs · 2026Article
- Intergenerational Transmission of Cannabis Use: Testing Genetic Risk and the Mitigating Influences of Parent Positive Behavior Support in Early Childhood.Research on child and adolescent psychopathology · 2025Article
- Trends in substance use-related emergency department visits by youth, 2018-2023.The American journal of emergency medicine · 2025Article
- Examining dynamic patterns of problematic cannabis use: Results from a multilevel network analysis.Journal of psychopathology and clinical science · 2025Article
- Commentary on Pessar et al.: 'Downscaling' United States state cannabis policy to investigate environmental and social impacts on cannabis use.Addiction (Abingdon, England) · 2025Article
- Substance Use among Youth Presenting to the Pediatric Emergency Department.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2025Article
- Cannabis Products and Use Patterns Associated with Cannabis Use Disorder Symptoms Among Youth in Southern California.Cannabis (Albuquerque, N.M.) · 2025Article
- Understanding the online landscape of cannabis discourse: a Twitter analysis.Frontiers in public health · 2025Article
- Cannabis use patterns and different phenotypes in relation to other drugs use: latent class analyses from the Sao Paulo Megacity Mental Health Survey.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2025Article
- Intensifying Substance Use Trends among Youth: A Narrative Review of Recent Trends and Implications.Current psychiatry reports · 2024Review
- Emergency Department Screening and Interventions for Adolescents With Substance Use: A Narrative Review.The Journal of emergency medicine · 2024Review
- Association between cannabis use and brain structure and function: an observational and Mendelian randomisation study.BMJ mental health · 2024Observational
- Executive functions and behavioral economic demand for cannabis among young adults: Indirect associations with cannabis consumption and cannabis use disorder.Experimental and clinical psychopharmacology · 2024Article
- The role of sex and drug use during adolescence in determining the risk for adverse consequences of amphetamines.Advances in pharmacology (San Diego, Calif.) · 2024Article
- Chronic exposure to inhaled vaporized cannabis high in ΔFrontiers in pharmacology · 2024Article
- Mental and Physical Health-Related Cannabis Motives Mediate the Relationship between Childhood Trauma and Problematic Cannabis Use over Time among Emerging Adult Cannabis Users.Substance use & misuse · 2024Article
- Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis.PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
aimThis study estimated whether and how the 12-month prevalence of cannabis use disorder among US youth aged 12-17 and emerging adults aged 18-25 varied by time since first cannabis use.
designRepeated cross-sectional survey data from the 2015-17 National Surveys on Drug Use and Health (NSDUH).
settingUnited States.
participantsA total of 101 000 NSDUH participants aged 12-25. MEASUREMENTS: Past 12-month cannabis use disorder was assessed using DSM-IV criteria.
findingsAmong youth, the life-time prevalence of cannabis use was 15.3% [95% confidence interval (CI) = 14.86-15.65%]. Among emerging adults, the life-time prevalence of cannabis use was 52.4% (95% CI = 51.77-53.01%). The adjusted 12-month prevalence of cannabis use disorder among youth with life-time cannabis use was 10.9% (95% CI = 9.24-12.75%) in the first year after starting cannabis use, 15.3% (95% CI = 13.68-17.12%) in the second year, 17.7% (95% CI = 15.55-19.97%) in the third year and 20.6% (95% CI = 18.23-23.17%) in the fourth year and beyond, which was consistently higher after the first year (linear trend only: P < 0.0001). The adjusted 12-month prevalence of cannabis use disorder among emerging adults with life-time use ranged from 5.6% (95% CI = 4.26-7.23%) in the first year after starting cannabis use, 7.7% (95% CI = 6.45-9.17%) in the second year and 9.1% (95% CI = 7.81-10.57%) in the third year to 10.5% (95% CI = 9.87%-11.12%) in the fourth year and beyond, which was consistently higher after the first year (linear trend only: P < 0.0001). Within each time-frame since first cannabis use, the adjusted 12-month prevalence of cannabis use disorder was higher among youth life-time users than their emerging adult counterparts.
conclusionsAmong youth and emerging adults in the United States, the prevalence of cannabis use disorder appears to increase with time since initiation of use and is higher among youth than among emerging adults during each examined time-frame.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.